Company Filing History:
Years Active: 2016
Title: Cheng-Kuo Lai: Innovator in Prostate Cancer Treatment
Introduction
Cheng-Kuo Lai is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of cancer treatment, particularly focusing on prostate cancer. His innovative approach aims to enhance the effectiveness of therapies for patients suffering from this condition.
Latest Patents
Cheng-Kuo Lai holds a patent for a method aimed at reducing the radio-resistance of prostate cancer cells. The patent, titled "Method for reducing radio-resistance of prostate cancer cells and/or treating prostate cancer," describes a technique that involves administering an effective amount of an active component. This active component is a nanoparticle carrier encapsulated with cytolethal distending toxin subunit B (CdtB). This innovative method has the potential to improve treatment outcomes for patients in need.
Career Highlights
Cheng-Kuo Lai is affiliated with China Medical University, where he continues to advance research in cancer therapies. His work is characterized by a commitment to developing effective treatment methods that can significantly impact patient care.
Collaborations
Cheng-Kuo Lai collaborates with esteemed colleagues, including Chih-Ho Lai and Yu-Hsin Lin. These partnerships enhance the research efforts and contribute to the development of innovative solutions in the medical field.
Conclusion
Cheng-Kuo Lai's contributions to prostate cancer treatment through his patented method exemplify the importance of innovation in medicine. His work not only reflects his dedication to improving patient outcomes but also highlights the collaborative spirit of research in the fight against cancer.